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Objectives: The study aimed to determine if utilization of the CodeHeart application (CHap) reduces door-to-
balloon (DTB) times of ST-segment elevation myocardial infarction (STEMI) patients.
Background: A pre-hospital electrocardiogram improves the management of patients with STEMI. Current
telecommunication systems do not permit real-time interaction with the initial care providers. Our institution
developed a novel telecommunications system based on a software application that permits real-time, two-
way video and voice interaction over a secured network.
Methods: All STEMI system activations after implementation of the CHap were prospectively entered into a
database. Consecutive CHap activations were compared to routine activations as controls, during the same
time period.
Results: A total of 470 STEMI system activations occurred; CHap was used in 83 cases (17.7%). DTB time was
reduced by the use of CHap when compared to controls (CHap 103 minutes, 95% CI [87.0–118.3] vs. standard
149 minutes, 95% CI [134.0–164.8], p b 0.0001), as was ﬁrst call-to-balloon time (CHap 70 minutes, 95% CI
[60.8–79.5] vs. standard 92 minutes, 95% CI [85.8–98.9], p = 0.0002). The percentage of ‘true positive’
catheterization laboratory activations was nominally higher with the use of CHap, although this did not reach
statistical signiﬁcance [CHap 47/83 (56.6%) vs. routine 178/387 (45.9%), p = 0.103].
Conclusion: The implementation of a two-way telecommunications system allowing real-time interactions
between interventional cardiologists and referring practitioners improves overall DTB time. In addition, it has
the potential to decrease the frequency of false activations, thereby improving the cost efﬁciency of a
network's STEMI system.
© 2014 Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Time to reperfusion is an essential component in the management
of patients with ST-segment elevation myocardial infarction (STEMI).
Decreasing door-to-balloon time (DTB), as a surrogate measure of
reperfusion effectiveness, has been shown to be associated with
improved survival [1,2].
Cardiovascular societies worldwide have established management
goals that stress the importance of rapid reperfusion [3,4]. Quality
initiatives in the United States have created systems of care with the
ability to achieve DTB times that meet practice guideline recommen-
dations in a substantial proportion of patients treated with primary
percutaneous coronary intervention (PCI) [5]. Despite this, there are
still opportunities for improvement [5–7]. Diagnostic dilemmas and
inconclusive electrocardiograms have recently been shown to contrib-
ute to the longest delays inmanagement [7]. These hold-ups occur both
in centers with and without PCI capabilities; however, patientser, 110 Irving Street, NW, Suite
x: +1 202 877 2715.
man).
ess under CC BY-NC-ND license.transferred from non-PCI-capable hospitals are particularly prone to
fall outside the recommended time standards of reperfusion [7–10].
Pre-hospital transmission of electrocardiograms improves DTB
times [11,12], and may have an impact over mortality [13,14].
However, current telecommunication systems are limited to the
transmission of a still electrocardiographic image and do not allow for
real-time interaction between the receiving team and the healthcare
providers attending to the patient in the ambulance or at the referring
institution. We propose the introduction of a tool that permits an
almost instantaneous two-way interaction between the initial
healthcare team and the receiving on-call interventional cardiologist.
This tool has the potential to enhance the management of patients
with a possible acute coronary syndrome (ACS) by reducing DTB time,
and by facilitating the initial diagnostic and decision-making process
that leads to the STEMI system activation.
We sought to determine the feasibility of implementing this novel
telecommunications system which allows real-time, video- and voice-
interaction between careproviders, takingplace over a securednetwork
compliant with the existing restrictions on transmission of health
information [The Health Insurance Portability and Accountability Act
(HIPAA)], and that is able toperformon readily availableplatforms, such
as a cellular video-phone, a tablet, a desktop or a laptop computer.
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2.1. Telecommunications technology
The evolution of currently used technology has been presented in
more detail [15]. In essence, the telecommunications system is based
on a software application that can be downloaded to various
commonly used platforms already available to ﬁrst responders in
the ﬁeld, to caregivers at non-PCI capable hospitals, and to specialist
physicians at a receiving institution. This software allows real-time,
two-way voice and video capabilities to run over a secure HIPPA-
compliant network, and provides the means for a direct contact with
the interventional cardiologist on call who becomes involved from the
initial stages of the STEMI management process.
With regard to the technical aspects of the application, video
streaming is carried out using the Livecast™ video system (LiveCast,
Vancuver, BC), which allows two-way video and audio transmissions
from multiple sources and across multiple ﬁle formats, in addition to
providing a way to manage and archive the individual interactions.
The implementation of this application in the care of patients
imposes the need for fully secured video and voice interactions. In
order to achieve a truly HIPPA compliant system, a virtual private
network application (Columbitech™ mobile virtual private network,
Stockholm Sweden), was adapted for our purposes to secure the video
immediately for transmission. This software allows encryption to be
integrated into the video streaming while permitting seamless access
to a webcasting application without the need for additional hardware.
In addition, the use of an efﬁcient virtual private network permits a
smooth transition from the wireless network to a mobile platform
without interruptions to the livestream, as well as supporting its use
on laptops and desktops connected to an institution's pre-existing
network (Fig. 1).
With the integration of the Livecast™ video system and the
Columbitech™ mobile virtual private network, a single turnkey
application named “CodeHeart” was created in order to make it
simple to install and very user friendly. The CodeHeart application
(CHap) was designed by the MedStar Health Research Institute based
on a grant from the Tauber Foundation and devised with the technical
support of the AT&T™ (Dallas, TX) engineering department.
An initial pilot study [16] ﬁrst evaluated the potential use of this
technology. Based on the initial results, subsequent development
followed until its introduction into clinical practice.Fig. 1. Representation of the C2.2. Catheterization laboratory activation
CHap was ﬁrst introduced in March 2011, and was evaluated
immediately after its deployment over a well-established regional
STEMI system of care comprised of multiple referral centers without
PCI capabilities and a central receiving PCI-capable institution. The
software application was downloaded to existing emergency room
laptop and desktop computers in all participating centers, as well as
those in the catheterization laboratories of the receiving hospital.
Cellular video-phones (iPhone 3G smart phone™, Palo Alto, CA)
equipped with the CHap were provided to regional ambulance teams
and to interventional cardiologists involved in accepting patients with
a possible ACS.
In the appropriate clinical scenario, a local caregiver directly
contacted the interventional cardiologist at the PCI-capable hospital
with the use of the CHap. Using the application, the care team brieﬂy
presented the case and showed the electrocardiogram to the
interventional cardiologist on call. (Fig. 2) Based on this interaction,
both parties would then decide on the best management approach,
which could include the activation of the catheterization laboratory for
possible primary PCI or an elective inter-hospital transfer for
subsequent observation or non-emergent PCI. When activation of the
catheterization laboratory was considered appropriate, the on-call
interventionalist activated the catheterization laboratory by contacting
a central number where an expediter mobilized the entire team, and
coordinated the transfer in the cases initiated at other institutions.
After implementation of the CHap, all interactions using the
systemwere recorded, and there were no exclusions. The interactions
regarding a possible ACS were archived and subsequently matched to
our institution's ongoing database of catheterization laboratory
activations. Matching involved date of intervention, timing of call,
referral site, interventionalist involved, and interventional outcome.
In addition, the accuracy of the matching details was conﬁrmed
against hospital admission and referral databases as well as quality
databases at MedStar Washington Hospital Center and the MedStar
Health Research Institute. CHap-generated activations were com-
pared to those utilizing standard channels of activation over the same
time period.
Of note, although the use of CHap was widely encouraged,
previously established channels of activation persisted concomitantly
and were more frequently used, especially during the initial months
after deployment.Hap software utilization.
Fig. 2. Screen shot of the CHap software being used on a mobile phone. It shows the
image of the referring physician explaining the case and that of the electrocardiogram
shown below.
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Primary source documents for all events were obtained and used
to adjudicate STEMI cases. Adjudications were performed by
physicians unaware of the activation system utilized during a
particular case. Quality measures pertaining to STEMI management
and system performance were adjudicated by a centralized dedicated
team not involved in the study.
The institutional review boards of MedStar Washington Hospital
Center and the MedStar Health Research Institute (Washington, DC)
approved this study. Experienced staff at a dedicated data-coordinat-
ing center performed all clinical data collection, entry, and analysis.
Data regarding baseline clinical and procedural data, together
with post-procedure inpatient events, were obtained from hospital
chart review.
2.4. Study deﬁnitions
Electrocardiographic criteria deﬁning a STEMI included the presence
of at least 1 mm of ST-segment elevation in at least two contiguous
leads, or the occurrence of a new left bundle branch block. A ‘true
positive’ catheterization laboratory activation was deﬁned as that in
which a STEMI was adjudicated based on electrocardiographic criteria,
and PCI or subsequent surgical revascularization was performed. ‘False
positive’ catheterization laboratory activations were deﬁned as those
activations that did not meet electrocardiographic criteria for STEMI or
those in which no revascularization was required.
The deﬁnition for DTB time was the time from ﬁrst registered
hospital contact to ﬁrst intervention that restored blood ﬂow to the
culprit vessel. For transferred patients, DTB time was the time from
ﬁrst registered hospital contact at the outside institution as recorded
on transfer records. Door-to-call was the time from hospital arrival to
the ﬁrst notiﬁcation given to the interventional cardiologist on call.
Call-to-labwas the time from initial call to arrival at the interventional
suite. Call-to-balloon is deﬁned as the time from initial call to the ﬁrst
intervention that restored blood ﬂow to the culprit vessel. Door-to-
EKG is the time from hospital arrival to ﬁrst electrocardiogram
considered to be STEMI qualifying according to preset criteria. EKG-
to-call is the time from qualifying electrocardiogram to ﬁrst call
notiﬁcation of a possible ACS. Other, more detailed parameters
recorded in our institution were: Lab-to-balloon, representing timefrom catheterization suite arrival to ﬁrst intervention that restored
ﬂow to the culprit vessel, lab-to-case start, as time from patient arrival
to the interventional suite to timewere ﬁrst invasive action took place
(generally initial stick) and case start-to-balloon as the time from ﬁrst
invasive action to ﬁrst intervention that restored blood ﬂow to the
culprit vessel.
In-hospital major adverse cardiac events (MACE) were deﬁned as
the occurrence of death from any cause, Q-wavemyocardial infarction
(MI) or target lesion revascularization (TLR) before hospital dis-
charge. Q-waveMI is deﬁned as an elevation of creatine kinase-MB≥3
times the upper normal value in the presence of new pathologic Q
waves in≥2 contiguous leads of the electrocardiogram. TLR is deﬁned
as clinically driven revascularization of the index lesion. PCI
angiographic success is deﬁned as a residual stenosis of b30% with
thrombolysis in myocardial infarction grade III ﬂow. Clinical success is
deﬁned as angiographic success plus the absence of TLR, Q-wave MI,
or death prior to hospital discharge.
2.5. Interventional treatment
PCI was performed according to guidelines current at the time of
the procedure. In all cases, the interventional strategy and the choice
of peri-procedural and discharge medications were at the discretion
of the responsible physician. Anticoagulation regimens included
either bivalirudin 0.75 mg/kg followed by an infusion of 1.75 mg/
kg/hour for the duration of the procedure or unfractionated heparin to
achieve an activated clotting time of 200–300 seconds in all patients.
All patients received an aspirin loading dose of 325 mg and were
prescribed 81–325 mg once daily indeﬁnitely. After a clopidogrel
loading dose of 300–600 mg, patients were prescribed 75 mg once
daily for ≥6 months in those who received a drug-eluting stent and
≥1 month in patients who received a bare metal stent.
2.6. Statistical analysis
Statistical analysis was performed using SAS version 9.1 (SAS Institute
Inc, Cary, NC). Normally distributed continuous variables are presented as
mean ± SD. Those variables not normally distributed are shown as
median ± interquartile range. Categorical variables are expressed as
frequencies and percentages. Baseline characteristics were compared
using Student's t test for parametric variables or the Mann–Whitney U
test when not normally distributed. Categorical variables were compared
using chi-square test or Fisher's exact test as appropriate.
3. Results
From 03/2011 to 03/2012, there were a total of 470 STEMI system
activations; CHap was used in 83 cases (17.7%). (Fig. 3) In the overall
population of STEMI cases, the mean age was 61 years. The majority
was male (69.6%) and Caucasian (52%), with 43.8% being African-
American. Baseline demographic and clinical characteristics of STEMI
patients who underwent PCI in which CHap was used were
comparable to those treated via standard channels of activation.
(Table 1) Likewise, baseline and angiographic procedural character-
istics between groups were very similar. (Table 2) Of note, non-
signiﬁcant trends toward higher incidences of diabetes mellitus and a
higher number of lesions treated were present in patients managed
via standard channels of activation.
In-hospital outcomes are presented in Table 3. None of the evaluated
end points differed signiﬁcantly between groups. An unfavorable trend
toward higher in-hospital MACE was present for patients managed via
standard channels of activation, contributed by cardiac death, urgent TLR,
and the need for coronary artery bypass surgery (Table 3).
Quality measures evaluating the STEMI system of care are
presented in Table 4. When the CHap was utilized to activate the
management ﬂow of a possible STEMI case, a signiﬁcantly shorter DTB
Fig. 3. Flow diagram of the STEMI system activations from 3/14/2011 to 3/31/2012. Comparison of CHap activations versus standard activations. *Note that on each route of
activation, cases could be further categorized as a STEMI or not a STEMI based on predeﬁned criteria. These were subsequently sub-categorized as receiving PCI or not. *Within
parenthesis is the corresponding number of cases that were transferred from outside institutions.
Table 2
Baseline angiographic and procedural characteristics.
Procedural characteristics CHap
(n = 47)
Standard
(n = 178)
p Value
Number of diseased vessels 1.55 ± 0.77 1.77 ± 0.82 0.11
Number of lesions treated 1.17 ± 0.43 1.33 ± 0.65 0.05
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standard 149 minutes, 95% CI [134.0–164.8], p b 0.0001). Similarly,
call-to-lab and call-to-balloon were signiﬁcantly shortened (CHap
33 minutes, 95% CI [26.2–40.1] vs. standard 56 minutes, 95% CI [49.9–
61.3], p b 0.0001) and (CHap 70 minutes, 95% CI [60.8–79.5] vs.
standard 92 minutes, 95% CI [85.8–98.9], p = 0.0002), respectively.
Notably, all parameters evaluating management before the initial
call (door-to-EKG, door-to-call and EKG-to-call) were similar be-
tween the two cohorts. Likewise, all parameters evaluating manage-
ment after arrival at the receiving hospital (lab-to-balloon, lab-to-case
start, and case start-to-balloon) did not differ between the two routes
used to activate the system of STEMI care.
Table 5 describes the rate of ‘true positive’ activations in each study
arm as a comparative measure of triage effectiveness. From the 470
STEMI system activations, CHap was used in 83 cases (17.7%),
compared to standard channels used in 387 cases (82.3%). (Fig. 3)
Of these, 49 (59%) were adjudicated as STEMI based on electrocar-
diographic criteria, in comparison to 193 (49.9%) for standard
activation. Forty-seven patients (56.6%) received PCI in contrast to
178 (45.9%) for standard activation (‘true positive’ activation).Table 1
Baseline characteristics.
CHap
(n = 47)
Standard
(n = 178)
p Value
Age (years) 59.46 ± 14.33 62.23 ± 13.10 0.21
Male gender 36 (76.6%) 120 (67.8%) 0.24
Caucasian 24 (51.1%) 93 (52.5%) 0.86
African-American 21 (44.7%) 77(43.5%) 0.89
Current smoker 25 (53.2%) 39.9 (14.5%) 0.10
Cardiogenic shock at presentation 2 (4.3%) 20 (11.2%) 0.18
History of chronic renal insufﬁciency 6 (12.8%) 25 (14.0%) 0.82
History of diabetes mellitus 7 (14.9%) 52 (29.2%) 0.05
History of hypertension 30 (63.8%) 131 (73.6%) 0.19
History of dyslipidemia 31 (66.0%) 110 (61.8%) 0.60
History of myocardial infarction 9 (19.6%) 22 (12.4%) 0.21
Previous percutaneous
coronary intervention
10 (21.3%) 25 (14.0%) 0.22
Previous coronary artery
bypass graft surgery
2 (4.3%) 12 (6.7%) 0.74
History of congestive heart failure 4 (8.5%) 23 (12.9%) 0.41
Left ventricular ejection fraction 0.39 ± 0.20 0.33 ± 0.21 0.14Therefore, the rate of ‘true positive’ activations based on STEMI
adjudication with subsequent PCI was nominally higher when CHap
was used; however, the difference did not reach statistical signiﬁ-
cance, (p = 0.103). A speciﬁc subgroup analysis of the rate of ‘true
positive’ activations for transferred patients demonstrated a similar
pattern to that found for the general cohort, and it is shown in Table 6.
4. Discussion
The primary ﬁnding of this study is that utilization of a
downloadable software application in the care process of a patient
with a possible ACS allows for a signiﬁcant reduction of total DTB timePre-intervention lesion stenosis
(visual estimation)
0.94 ± 0.09 0.95 ± 0.10 0.78
Post-intervention lesion stenosis
(visual estimation)
0.05 ± 0.14 0.07 ± 0.15 0.38
Implanted stent diameter 2.75 ± 0.39 2.88 ± 0.32 0.16
Implanted stent length 22.7 ± 22.12 19.86 ± 5.86 0.60
Intraprocedural bivalirudin use 43 (91.5%) 160 (89.9%) 1.00
Angiographic characteristics (lesion based)
Angiographic success 55/57 (96.5%) 236/242 (97.5%) 0.65
Left anterior descendent artery PCI 17/57 (29.8%) 90/241 (37.3%) 0.29
Left circumﬂex artery PCI 13/57 (22.8%) 45/241 (18.7%) 0.45
Right coronary artery PCI 27/57 (47.4%) 99/241 (41.1%) 0.39
Saphenous vein graft PCI 0/57 (0.0%) 2/241 (0.8%) 1.00
ACC/AHA type A lesion 3/57 (5.3%) 19/239 (7.9%) 0.78
ACC/AHA type B1/B2 lesion 35/57 (61.4%) 120/239 (50.2%) 0.13
ACC/AHA type C lesion 19/57 (33.3%) 100/239 (41.8%) 0.24
PCI to an ostial lesion 0/57 (0.0%) 3/242 (1.2%) 1.00
PCI to a lesion with in-stent
restenosis
3/57 (5.3%) 5/241 (2.1%) 0.18
Balloon used for pre-dilatation 27/57 (47.4%) 107/242 (44.2%) 0.67
Balloon used for post-dilatation 4/57 (7.0%) 34/242 (14.0%) 0.15
PCI, percutaneous coronary intervention; ACC/AHA, American College of Cardiology/
American Heart Association.
Table 3
In-hospital outcomes.
CHap (n = 47) Standard (n = 178) p Value
In-hospital MACE ⁎ 2 (4.3%) 25 (14.0%) 0.07
Death 2 (4.3%) 13 (7.3%) 0.74
Cardiac death 1 (2.1%) 12 (6.7%) 0.31
Q-wave myocardial infarction 0 0
Urgent target lesion
revascularization
0 5 (2.8%) 0.59
Coronary artery bypass
graft surgery
0 7 (3.9%) 0.35
Clinical success 45 (95.7%) 153 (86.0%) 0.07
⁎ In-hospital major adverse cardiac events (MACE) deﬁned as: In-hospital all-cause
death, Q-wave myocardial infarction, urgent target lesion revascularization, urgent
coronary artery bypass surgery.
Table 5
Comparison of triage efﬁcacy for overall cohort. CodeHeart Application (CHap) vs
Standard channels of STEMI activation.
CHap (n = 83) Standard (n = 387) p Value
STEMI adjudicated 49 (59%) 193 (49.9%) 0.163
True positive activation 47 (56%) 178 (46%) 0.101
False positive activation 36 (43.4%) 209 (54%)
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the time from the initial call to the time of arrival into the
catheterization laboratory.
The use of telecommunication systems is considered valuable in
the care of patients with STEMI, and has been shown to improve the
quality of patient care [11–14]. STEMI management in regional
networks of care has beneﬁtted from the implementation of pre-
hospital electrocardiograms [13,14,17,18]. This crucial step improves
risk stratiﬁcation of a patient with possible ACS, and permits
appropriate decisions to be made regarding the urgency and level of
care required. Moreover, it reduces improper utilization of resources,
such as ambulance transfer to non PCI-capable centers or inappro-
priate catheterization laboratory activations.
An initial pilot study published by Gonzalez et al. [16] presented
proof of concept for the use of a downloadable software application in
the management of patients with a possible ACS. This software
installed on a cellular video-phone permitted a reliable and consistent
interpretation of an electrocardiogram, where the measured inter-
physician reliability and the time to interpret the electrocardiogram
transmitted electronically was as good as that achieved with direct
interpersonal communication, with a slightly longer time to complete
the interaction [16].
The presented data pertains to the ﬁrst 12 months after clinical
implementation of original software called “CHap”, which is used for
the triage of patients with a possible ACS. The results could be
attributed to some theoretical advantages found on the product design
from its inception. The initial objectives were to create an affordable
telecommunications system that worked on multiple commonly used
platforms that permitted real-time, good quality video and voice
transmission, that was simple to use, and was HIPPA compliant.
The simplicity of use and the ability to download this application to
multiple stationary or mobile platformsmakes this technology readilyTable 4
Quality measures for STEMI management.
CHap (n = 47)
minutes mean [95%CI]
Standard (n = 178)
minutes mean [95%CI]
p Value
Door-to-balloon 102.6 [87.0–118.3] 149.4 [134.0–164.8] b0.0001
Door-to-EKG 17.7 [4.0–31.5] 16.3 [11.7–20.9] 0.841
Door-to-call 50.4 [11.7–89.03] 80.3 [30.8–129.9] 0.343
Call-to-lab 33.2 [26.2–40.1] 55.6 [49.9–61.3] b0.0001
Call-to-balloon 70.2 [60.8–79.5] 92.3 [85.8–98.9] 0.0002
Lab-to-balloon 37.8 [33.4–42.2] 36.9 [34.5–39.2] 0.706
Lab-to-case start 16.7 [13.4–20.1] 15.9 [14.6–17.2] 0.655
EKG-to-call 34.8 [0.9–68.7] 96.7 [32.7–160.6] 0.091
Case start-to-balloon 21.1 [18.2–23.9] 21.0 [19.1–22.8] 0.948
Cath lab (catheterization laboratory), door-to-EKG (door to ﬁrst electrocardiogram),
door-to-call (door to ﬁrst call), call-to-lab (ﬁrst call to cath lab arrival), call-to-balloon
(ﬁrst call to balloon), lab-to-balloon (cath lab arrival to balloon), lab-to-case start (cath
lab arrival to case start), EKG-to-call (electrocardiogram to ﬁrst call), case start-to-
balloon (case start to balloon).
Table 6
Comparison of triage efﬁcacy for transferred patients. CodeHeart Application (CHap) vs
standard channels of STEMI activation.
CHap (n = 37) Standard (n = 251) p Value
STEMI adjudicated 25 (67.6%) 145 (57.8%) 0.163
True positive activation 24 (64.9%) 134 (53.4%) 0.257
False positive activation 13 (35.1%) 117 (46.6%).available, allowing continuous direct access to the interventional
cardiologist and bypassing any potential delays in locating the
appropriate person in the roster. It also allows the interventional
cardiologist to fully grasp the salient patient characteristics and
particular clinical circumstances early in the process of care and
directly from the initial provider, an interaction that can occur at night
or during weekends while the receiving practitioner is away from the
hospital where a ﬁxed network would exist. This involvement may
help to promote appropriate activation of the cath lab and to
encourage efﬁcient reperfusion for a STEMI.
The potential advantage of having an experienced interventional-
ist engaged in the early stages of the triage process is supported by a
study revealing that up to 1/3 of all patients transferred for primary
PCI, encounter signiﬁcant delays and inadequate DTB times. These
delays are commonly due to diagnostic dilemmas and non-diagnostic
electrocardiograms that may result in emergency department hold-
ups [7]. An earlier involvement of an interventional cardiologist may
reduce these diagnostic delays.
Notably, when the different steps in the STEMI management
process were evaluated, CHap impacted the STEMI management
process by a reduction of the time from the initial call to the arrival at
the interventional suite. It is conceivable that during this crucial step,
specialized guidance could contribute to the resolution of diagnostic
dilemmas or uncertain electrocardiograms, as well as to expedite all
parties for urgent patient transfer to the cath lab, which would
translate in shorter DTB times and speedy reperfusions.
Although portable deﬁbrillators and monitors have the ability to
transmit electrocardiograms effectively through a preconﬁgured
network [12], a more manageable and inexpensive telecommunica-
tions system allows wider access at lower costs, while maintaining
good reliability and performance.
CHap brings substantial advantages over ﬁxed systems that are less
mobile, require costly subscriptions, and use additional hardware. This
easily accessible system may have important implications in the
widespread adoption of this technology. Its availability to institutions
with limited resources would particularly beneﬁt, as these institutions
usually do not have on-site PCI and participate in a larger referral
network of care. In addition, early direct interaction with experienced
interventional cardiologists has the potential to elevate the overall quality
of care of ACS patients at both referral institutions and PCI centers.
4.1. Limitations
There are several limitations to this study. Although the enrollment
was prospective and all-inclusive, the comparison groups were not
randomized, which may result in strong selection bias. Also, the fact
that it represents the experience of single center makes it subject to the
known shortcomings of such evaluations. Retrospective matching was.
268 G.L. Sardi et al. / Cardiovascular Revascularization Medicine 15 (2014) 263–268performed to pair the cath lab database with the CHap archive, and
although all cases were matched by multiple factors and corroborated
with hospital records and other databases, sources of error were
minimized but nonetheless possible. Additionally, our system of care
may have certain referral characteristics and particular management
features that may not make this information generalizable.
Lastly, this study evaluates the initial introduction of a telecom-
munications system, which ran concurrently with standard channels
of activation. While this has some comparative value in itself,
established patterns of management made the initial acceptance of
this new technology difﬁcult, which translated to a relatively
infrequent use of the CHap software compared to regular channels
(CHap was used in 17% of all STEMI system activations).
Those patients treated after activation of the CHap system could be
the subject of a biased selection, which cannot be excluded despite the
fact that clinical and angiographic characteristics were compared in
detail and were found to be statistically similar. Still, the derived
limited number of CHap activations may have underpowered our
ability to detect differences between groups.
While we cannot rule out that the higher number of regular
activations represents a preference for the conventional system, we
believe it represents a normal process of acceptance to a newly
implemented tool that drastically alters long-established patterns of
behavior. This assumption is based on positive feedback from referral
institutions and from the progressively increased use in the CHap
system over the 12-month period evaluated in this study.
5. Conclusion
The implementation of a two-way telecommunications system that
allows for real-time interactions between the on-call interventional
cardiologist and referring practitioners improves overall DTB time. In
addition, non-signiﬁcant trends suggesting fewer false activations may
improve the cost efﬁciency of a network's STEMI system. Larger,
randomized comparisons are necessary to conﬁrm our ﬁndings.
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